BSE filing, NSE: COFFEEDAY. Summary written from the filing by ALFA Finder's alert engine.
Coffee Day Enterprises Ltd: key numbers
- Share price
- ₹29.20
- Market cap
- ₹616.9 Cr
- Revenue (annual)
- ₹1,116 Cr
- Net profit (annual)
- ₹203.1 Cr
- P/E (TTM)
- 3.5×Sector 43.4×
- Promoter holding
- 7.77%+0.03% QoQ
- FII holding
- 0.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coffee Day Enterprises Ltd
All →Coffee Day Enterprises Other Announcement
Coffee Day Enterprises Ltd has submitted its quarterly shareholding pattern disclosure as per SEBI regulations, detailing the shareholding distribution among various categories of investors.
Coffee Day Enterprises Debt & Borrowing: ₹25 Cr
Coffee Day Enterprises Limited has completed a One Time Settlement (OTS) with Kemfin Services Private Limited for ₹25 Crore. This settlement resolves all outstanding dues to reduce debt.
- Value
- ₹25.00 Cr
Coffee Day Enterprises Board Meeting Date
Coffee Day Enterprises scheduled a board meeting on November 6, 2026, to consider and approve standalone and consolidated unaudited financial results.
Coffee Day Enterprises Share Pledge
Coffee Day Consolidations released 47,293 invoked pledged shares of Coffee Day Enterprises. The reversal, tied to borrowings assigned to Phoenix ARC, zeroed encumbered holdings.
Coffee Day Enterprises Annual General Meeting
Coffee Day Enterprises Limited held its 18th Annual General Meeting on September 21, 2026, via video conferencing to transact the company's ordinary business items.
Coffee Day Enterprises Annual General Meeting
Coffee Day Enterprises Limited has issued the notice for its 18th Annual General Meeting scheduled for September 21, 2026. Key agenda items include the adoption of audited financial statements.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.